XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck

PURPOSE: Tumor-specific biomarkers that predict resistance to DNA damaging agents may improve therapeutic outcomes by guiding the selection of effective therapies and limiting morbidity related to ineffective approaches. XPF (ERCC4) is an essential component of several DNA repair pathways and XPF-de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vaezi, Alec, Wang, XiaoZhe, Buch, Shama, Gooding, William, Wang, Lin, Seethala, Raja R., Weaver, David T., D’Andrea, Alan D., Argiris, Athanassios, Romkes, Marjorie, Niedernhofer, Laura J., Grandis, Jennifer R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3156890/
https://ncbi.nlm.nih.gov/pubmed/21737503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0086
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados